0
Skip to Content
Expert Vaccine Analysis Team
Home
Who We Are
Meet the Team
Key Vaccine Topics
Evidence-Based Resources
Webinars & Podcasts
Select Coverage
Contact Us
Expert Vaccine Analysis Team
Home
Who We Are
Meet the Team
Key Vaccine Topics
Evidence-Based Resources
Webinars & Podcasts
Select Coverage
Contact Us
Home
Folder: About
Back
Who We Are
Meet the Team
Folder: Resources
Back
Key Vaccine Topics
Evidence-Based Resources
Webinars & Podcasts
Folder: In the News
Back
Select Coverage
Contact Us

Moderna’s mRNA flu vaccine more effective than standard shot in late-stage trial

May 6
Written by Marcela Aguilar
Marcela Aguilar
Previous
Previous

How to restore credibility to the CDC’s vaccine advisory committee

Next
Next

The Persistent Misleading Claim That Vaccines Aren’t Properly Tested for Safety

Stay Informed

Sign up to receive EVAT updates.

Resources
Key Vaccine Topics
Evidence-Based Resources
Webinars & Podcasts

About Us
Who We AreMeet the Team EVAT Factsheet

Subscribe

In the News
Select Coverage

© 2026 Georgetown University